Terms: = Germ cell tumor AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
266 results:
1. Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma.
Wang C; Liu X; Guo S
BMC Complement Med Ther; 2023 Oct; 23(1):371. PubMed ID: 37865727
[TBL] [Abstract] [Full Text] [Related]
2. Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy.
Hou C; Shi S; Gao M; Ji J; Ma C; Wang T; Chen T; Liu Y; Zhong J; Zheng Y; Ye J; Ke Y
J Neurooncol; 2023 Oct; 165(1):79-90. PubMed ID: 37819535
[TBL] [Abstract] [Full Text] [Related]
3. Combined BRAF, MEK, and heat-shock protein 90 inhibition in advanced BRAF V600-mutant melanoma.
Eroglu Z; Chen YA; Smalley I; Li J; Markowitz JK; Brohl AS; Tetteh L; Taylor H; Sondak VK; Khushalani NI; Smalley KSM
Cancer; 2024 Jan; 130(2):232-243. PubMed ID: 37776537
[TBL] [Abstract] [Full Text] [Related]
4. Promising targetable biomarkers in pancreatic neuroendocrine tumours.
Borghesani M; Gervaso L; Cella CA; Benini L; Ciardiello D; Algeri L; Ferrero A; Valenza C; Guidi L; Zampino MG; Spada F; Fazio N
Expert Rev Endocrinol Metab; 2023; 18(5):387-398. PubMed ID: 37743651
[TBL] [Abstract] [Full Text] [Related]
5. Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking.
Su J; Huo M; Xu F; Ding L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1551-1559. PubMed ID: 37668687
[TBL] [Abstract] [Full Text] [Related]
6. Chrysin and chrysin-loaded nanocarriers induced immunogenic cell death on B16 melanoma cells.
Oliyapour Y; Dabiri S; Molavi O; Hejazi MS; Davaran S; Jafari S; Montazersaheb S
Med Oncol; 2023 Aug; 40(10):278. PubMed ID: 37624439
[TBL] [Abstract] [Full Text] [Related]
7. AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression.
Wan S; Liu C; Li C; Wang Z; Zhao G; Li J; Ran W; Zhong X; Li Y; Zhang L; Cui H
Oncogene; 2023 Sep; 42(39):2905-2918. PubMed ID: 37596322
[TBL] [Abstract] [Full Text] [Related]
8. CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma.
Chuah YH; Tay EXY; Grinchuk OV; Yoon J; Feng J; Kannan S; Robert M; Jakhar R; Liang Y; Lee BWL; Wang LC; Lim YT; Zhao T; Sobota RM; Lu G; Low BC; Crasta KC; Verma CS; Lin Z; Ong DST
Cell Death Differ; 2023 Aug; 30(8):1973-1987. PubMed ID: 37468549
[TBL] [Abstract] [Full Text] [Related]
9. Identification of circRNA-miRNA-mRNA Network Regulated by hsp90 in Human Melanoma A375 cells.
Fu Q; Gao H; Liu K; Su J; Zhang J; Guo X; Yang F
Comb Chem High Throughput Screen; 2024; 27(2):307-316. PubMed ID: 37303182
[TBL] [Abstract] [Full Text] [Related]
10. In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity.
Ma S; Huis In't Veld RV; Houy A; Stern MH; Rich C; Ossendorp FA; Jager MJ
Invest Ophthalmol Vis Sci; 2023 Jun; 64(7):10. PubMed ID: 37272766
[TBL] [Abstract] [Full Text] [Related]
11. Elucidating the toxic effect and disease mechanisms associated with Lyso-Gb3 in Fabry disease.
Nikolaenko V; Warnock DG; Mills K; Heywood WE
Hum Mol Genet; 2023 Jul; 32(15):2464-2472. PubMed ID: 37145097
[TBL] [Abstract] [Full Text] [Related]
12. Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors.
Mooradian MJ; Cleary JM; Giobbie-Hurder A; Darville LNF; Parikh A; Buchbinder EI; Cohen JV; Lawrence DP; Shapiro GI; Keer H; Chen HX; Ivy SP; Smalley KSM; Koomen JM; Sullivan RJ
Cancer; 2023 Jun; 129(12):1904-1918. PubMed ID: 37042037
[TBL] [Abstract] [Full Text] [Related]
13. ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.
Mainwaring OJ; Weishaupt H; Zhao M; Rosén G; Borgenvik A; Breinschmid L; Verbaan AD; Richardson S; Thompson D; Clifford SC; Hill RM; Annusver K; Sundström A; Holmberg KO; Kasper M; Hutter S; Swartling FJ
Nat Commun; 2023 Mar; 14(1):1221. PubMed ID: 36869047
[TBL] [Abstract] [Full Text] [Related]
14. Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases.
Chen Q; Li K; Rhodin KE; Masoud SJ; Lidsky ME; Cai J; Wei Q; Luo S; Zhao H
J Surg Oncol; 2023 May; 127(6):945-955. PubMed ID: 36807890
[TBL] [Abstract] [Full Text] [Related]
15. FKBP51 plays an essential role in Akt ubiquitination that requires hsp90 and PHLPP.
Tufano M; Marrone L; D'Ambrosio C; Di Giacomo V; Urzini S; Xiao Y; Matuozzo M; Scaloni A; Romano MF; Romano S
Cell Death Dis; 2023 Feb; 14(2):116. PubMed ID: 36781840
[TBL] [Abstract] [Full Text] [Related]
16. Hsp27, Hsp60, Hsp70, or hsp90 depletion enhances the antitumor effects of resveratrol via oxidative and ER stress response in human glioblastoma cells.
Önay Uçar E; Şengelen A; Mertoğlu Kamalı E
Biochem Pharmacol; 2023 Feb; 208():115409. PubMed ID: 36603687
[TBL] [Abstract] [Full Text] [Related]
17. Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma.
Sadeghi R; Pirankuraim H; Javanshir ST; Arabi M; Bereimipour A; Javanshir HT; Mahmoodzadeh H; Nayernia K
Eye (Lond); 2023 Aug; 37(11):2327-2334. PubMed ID: 36528757
[TBL] [Abstract] [Full Text] [Related]
18. hsp90 facilitates stemness and enhances glycolysis in glioma cells.
Kang X; Chen J; Hou JF
BMC Neurol; 2022 Nov; 22(1):420. PubMed ID: 36368999
[TBL] [Abstract] [Full Text] [Related]
19. Effects of cancer-associated point mutations on the structure, function, and stability of isocitrate dehydrogenase 2.
Chen X; Yang P; Qiao Y; Ye F; Wang Z; Xu M; Han X; Song L; Wu Y; Ou WB
Sci Rep; 2022 Nov; 12(1):18830. PubMed ID: 36335201
[TBL] [Abstract] [Full Text] [Related]
20. Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma cells.
Cappabianca L; Sebastiano M; Ruggieri M; Sbaffone M; Zelli V; Farina AR; Mackay AR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142807
[TBL] [Abstract] [Full Text] [Related]
[Next]
